Medicare plans to keep paying for telehealth services through next year. Two large health systems announce they won’t offer Biogen’s new Alzheimer’s drug. And in attempts to drive down prescription drug prices, states target the industry middlemen.
Hosted on Acast. See acast.com/privacy for more information.
